Lumida
/CERT
⌘K
Certara Inc

Certara Inc

CERT
$6.93USD↓-4.81%-0.35 today

MARKET CAP

1.1B

P/E (TTM)

17.8x

FWD P/E

15.9x

DAY RANGE

$7 – $7

52W RANGE

$4
$14

AI Summary

Stalk
Buy NowHigh

CERT is in a Stage 2 advancing phase with a medium-term bullish bias underscored by a confirmed Momentum Breakout and rising EMAs. Price is currently pulling back into the rising 9 EMA and 20 EMA without signs of exhaustion, offering favorable execution timing. The long-term trend remains bearish, anchored by a declining 200 DMA. Buy now to engage continuation participation on shallow pullbacks into EMAs.

  • ↑Software revenue rose 7% YoY to $49.7M in Q1 2026, driving top-line growth.
  • ↑AI integration and FDA’s animal-testing phase-out create regulatory tailwinds.
  • ↓Service revenue fell 4% in Q1 2026, reflecting Tier 1 client caution.
Full analysis →
Insider Trades39 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Jun 1, 2026SellCERTRona AnhaltChief Human Resources Officer2,241$5.82$1.1B-50.07%+55.73%$13.0K-8.56%—Buy Now
Jun 1, 2026SellCERTDaniel CorcoranSVP and General Counsel12,103$5.82$1.1B-50.07%+55.73%$70.4K-15.69%—Buy Now
May 11, 2026SellCERTJon Matthew ResnickChief Executive Officer24,377$6.31$1.1B-50.07%+55.73%$153.8K-0.94%—Buy Now
Apr 1, 2026SellCERTAdrian MckemeyPresident, Drug Dev. Solutions2,642$5.70$1.1B-50.07%+55.73%$15.1K-8.12%—Buy Now
Apr 1, 2026SellCERTRona AnhaltChief Human Resources Officer3,062$5.70$1.1B-50.07%+55.73%$17.5K-8.88%—Buy Now
Apr 1, 2026SellCERTDaniel CorcoranSVP and General Counsel5,751$5.70$1.1B-50.07%+55.73%$32.8K-11.79%—Buy Now
Apr 1, 2026SellCERTLeif E PedersenPRESIDENT, CHIEF COMMERCAL OFF11,611$5.70$1.1B-50.07%+55.73%$66.2K-2.66%—Buy Now
Apr 1, 2026SellCERTJohn E GallagherChief Financial Officer25,108$4.72$1.1B-50.07%+55.73%$118.5K-6.37%—Buy Now
Apr 1, 2026SellCERTRobert AspburyPRESIDENT, PREDICTIVE TECH22,411$5.70$1.1B-50.07%+55.73%$127.7K-1.66%—Buy Now
Nov 11, 2025BuyCERTWilliam F FeeheryCHIEF EXECUTIVE OFFICER24,096.384$8.30$1.1B-50.07%+55.73%$200.0K+1.03%—Buy Now
Sep 9, 2025SellCERTLeif E PedersenPRESIDENT, CHIEF COMMERCAL OFF51,224$10.92$1.1B-50.07%+55.73%$559.4K-40.91%10b5-1Buy Now
May 30, 2025SellCERTRona AnhaltChief Human Resources Officer1,965$11.40$1.1B-50.07%+55.73%$22.4K-9.17%—Buy Now
May 30, 2025SellCERTDaniel CorcoranSVP and General Counsel6,607$11.40$1.1B-50.07%+55.73%$75.3K-11.15%—Buy Now
Apr 1, 2025SellCERTLeif E PedersenPRESIDENT, CHIEF COMMERCAL OFF8,209$9.90$1.1B-50.07%+55.73%$81.3K-1.66%—Buy Now
Apr 1, 2025SellCERTJohn E GallagherPRESIDENT, CHIEF COMMERCAL OFF14,176$9.90$1.1B-50.07%+55.73%$140.3K-8.41%—Buy Now
Apr 1, 2025SellCERTRobert AspburyPRESIDENT, PREDICTIVE TECH15,846$9.90$1.1B-50.07%+55.73%$156.9K-1.27%—Buy Now
Apr 1, 2025SellCERTWilliam F FeeheryCHIEF EXECUTIVE OFFICER53,834$9.90$1.1B-50.07%+55.73%$533.0K-0.57%—Buy Now
Oct 7, 2024SellCERTPatrick F SmithPRESIDENT, DRUG DEV SOLUTIONS5,409$11.03$1.1B-50.07%+55.73%$59.7K-9.75%10b5-1Buy Now
Oct 4, 2024SellCERTPatrick F SmithPRESIDENT, DRUG DEV SOLUTIONS1,742$10.99$1.1B-50.07%+55.73%$19.1K-2.43%—Buy Now
Sep 9, 2024SellCERTLeif E PedersenPRESIDENT, CHIEF COMMERCAL OFF51,224$11.29$1.1B-50.07%+55.73%$578.3K-33.94%10b5-1Buy Now
Jul 1, 2024SellCERTRobert AspburyPRESIDENT, SCIENTIFIC SOFTWARE862$13.85$1.1B-50.07%+55.73%$11.9K-0.30%—Buy Now
Apr 2, 2024SellCERTPatrick F SmithPRESIDENT, DRUG DEV SOLUTIONS14,427$16.85$1.1B-50.07%+55.73%$243.2K-4.20%10b5-1Buy Now
Apr 1, 2024SellCERTNicolette D ShermanCHIEF HUMAN RESOURCES OFFICER2,578$17.88$1.1B-50.07%+55.73%$46.1K-3.39%—Buy Now
Apr 1, 2024SellCERTLeif E PedersenPRESIDENT, CHIEF COMMERCAL OFF5,951$17.88$1.1B-50.07%+55.73%$106.4K-1.20%—Buy Now
Apr 1, 2024SellCERTPatrick F SmithPRESIDENT, DRUG DEV SOLUTIONS6,955$17.88$1.1B-50.07%+55.73%$124.4K-2.91%—Buy Now
Apr 1, 2024SellCERTJohn E GallagherCHIEF FINANCIAL OFFICER9,077$17.88$1.1B-50.07%+55.73%$162.3K-7.40%—Buy Now
Apr 1, 2024SellCERTRichard M. TraynorSVP AND GENERAL COUNSEL9,244$17.92$1.1B-50.07%+55.73%$165.6K-1.29%10b5-1Buy Now
Apr 1, 2024SellCERTRobert AspburyPRESIDENT; SCIENTIFIC SOFTWARE10,625$17.88$1.1B-50.07%+55.73%$190.0K-1.15%—Buy Now
Apr 1, 2024SellCERTWilliam F FeeheryCHIEF EXECUTIVE OFFICER42,629$17.88$1.1B-50.07%+55.73%$762.2K-0.61%—Buy Now
Mar 5, 2024SellCERTNicolette D ShermanCHIEF HUMAN RESOURCES OFFICER2,373$18.88$1.1B-50.07%+55.73%$44.8K-11.25%—Buy Now
Mar 5, 2024SellCERTRichard M. TraynorSVP AND GENERAL COUNSEL3,660$18.88$1.1B-50.07%+55.73%$69.1K-2.11%—Buy Now
Mar 5, 2024SellCERTLeif E PedersenPRESIDENT, CHIEF COMMERCAL OFF4,050$18.88$1.1B-50.07%+55.73%$76.5K-2.80%—Buy Now
Mar 5, 2024SellCERTRobert AspburyPRESIDENT; SCIENTIFIC SOFTWARE7,311$18.88$1.1B-50.07%+55.73%$138.0K-1.27%—Buy Now
Mar 5, 2024SellCERTWilliam F FeeheryCHIEF EXECUTIVE OFFICER17,557$18.88$1.1B-50.07%+55.73%$331.5K-0.78%—Buy Now
Mar 4, 2024SellCERTRichard M. TraynorSVP AND GENERAL COUNSEL3,000$18.28$1.1B-50.07%+55.73%$54.8K-1.81%10b5-1Buy Now
Feb 20, 2024SellCERTPatrick F SmithPRESIDENT, DRUG DEV SOLUTIONS5,000$18.00$1.1B-50.07%+55.73%$90.0K-8.34%10b5-1Buy Now
Feb 12, 2024SellCERTRichard M. TraynorSVP AND GENERAL COUNSEL6,000$18.00$1.1B-50.07%+55.73%$108.0K-3.50%10b5-1Buy Now
Dec 26, 2023SellCERTRichard M. TraynorSVP AND GENERAL COUNSEL6,000$18.00$1.1B-50.07%+55.73%$108.0K-3.38%10b5-1Buy Now
Sep 11, 2023SellCERTLeif E PedersenPRESIDENT, CHIEF COMMERCAL OFF51,224$14.60$1.1B-50.07%+55.73%$747.9K-28.44%10b5-1Buy Now